Medicine and Dentistry

1. Patient 100%
2. Neoplasm 91%
3. Neoadjuvant Chemotherapy 67%
4. Adenocarcinoma 55%
5. Surgical Margin 51%
6. Positron Emission Tomography-Computed Tomography 46%
7. Therapeutic Procedure 41%
8. Hazard Ratio 39%
9. Analysis 38%
10. Chemotherapy 34%
11. Neoadjuvant Therapy 30%
12. Stomach Adenocarcinoma 29%
13. Malignant Neoplasm 28%
14. Esophageal Adenocarcinoma 28%
15. Adjuvant Therapy 25%
16. Esophagus 25%
17. Cardia 23%
18. Local Excision 23%
19. Glucose 23%
20. Chemotherapy Regimens 23%
21. Medical Research 23%
22. Treatment Response 23%
23. Association 23%
24. Dynamic Contrast-Enhanced MRI 23%
25. Fluorodeoxyglucose F 18 23%
26. Esophagectomy 23%
27. Adjuvant Chemoradiotherapy 14%
28. Mixed Tumor 13%
29. Age 11%
30. Proportional Hazards Model 10%
31. Esophageal Cancer 10%
32. Tumor Regression 9%
33. Vascular Tissue Neoplasm 9%
34. Recurrent Disease 9%
35. Cancer Staging 8%
36. Cohort Analysis 7%
37. Hospital 7%
38. Overall Survival 6%
39. Primary Tumor 6%
40. Lymph Node 6%
41. Adverse Event 6%
42. Postoperative Complication 6%
43. Cancer Surgery 6%
44. Mortality 5%
45. Morbidity 5%
46. Tumor Recurrence 5%
47. Stomach Tumor 5%
48. Survival Analysis 5%